Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 21:11:718.
doi: 10.3389/fmicb.2020.00718. eCollection 2020.

Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections

Roberta Gaziano  1 , Samuele Sabbatini  2 , Elena Roselletti  2 , Stefano Perito  2 , Claudia Monari  2
Affiliations
Review

Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections

Roberta Gaziano et al. Front Microbiol. .

Abstract

Vaginal infections affect 70% of women during their lifetimes and account for millions of annual doctors' visits. These infections are predominantly represented by vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV). Although standard antimicrobial agents remain the major strategy for the prevention and treatment of vaginal infections, both VVC and BV are difficult to treat due to high rates of resistance and recurrence, high probability of complications, and negative effects on the vaginal microbiota. This review focuses on a new approach of yeast-based probiotics for the prevention and/or treatment of these common vaginal infections.

Keywords: Saccharomyces cerevisiae; bacterial vaginosis; probiotics; vaginal microbiota; vulvovaginal candidiasis.

PubMed Disclaimer

References

    1. Abdel-Kareem M. M., Rasmey A. M., Zohri A. A. (2019). The action mechanism and biocontrol potentiality of novel isolates of Saccharomyces cerevisiae against the aflatoxigenic Aspergillus flavus. Lett. Appl. Microbiol. 68 104–111. 10.1111/lam.13105 - DOI - PubMed
    1. Adeniyi-Jones C., Groves D. J., Mannethu A., Righter J. (1980). Hemophilus vaginalis bacteremia. Can. Med. Assoc. J. 122 424–426. - PMC - PubMed
    1. Ahmed A., Earl J., Retchless A., Hillier S. L., Rabe L. K., Cherpes T. L., et al. (2012). Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J. Bacteriol. 194 3922–3937. 10.1128/JB.00056-12 - DOI - PMC - PubMed
    1. Allsworth J. E., Peipert J. F. (2011). Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am. J. Obstet. Gynecol. 205 113.e1–113.e6. 10.1016/j.ajog.2011.02.060 - DOI - PMC - PubMed
    1. Alves P., Castro J., Sousa C., Cereija T. B., Cerca N. (2014). Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. J. Infect. Dis. 210 593–596. 10.1093/infdis/jiu131 - DOI - PubMed

LinkOut - more resources